ARTLArtelo Biosciences Inc
$1.38
$0.05
(3.50%)
Closed $1.38
$0.0299
(2.17%)
After Hours
Mkt Cap$4.98M
Vol287,508.00
Fundamentals
Mkt Cap
$4.98M
Volume
-
52W High
$85.80
52W Low
$1.19
PE Ratio
-0.04
Avg. Volume
2.99M
EPS (Annual)
-$37.55
Rev/Employee
$0.00
Earnings
-
Traders Rush into AI, Biotech, and Emerging Tech
Momentum traders are aggressively rotating into AI infrastructure, biotech catalysts, blockchain exposure, and emerging technology plays as speculative appetite continues heating up across small-cap and high-growth sectors. $KBLB, $OTLK, $PHGE, $UZX, $QTEK $ARTL, $VCIG, $YMAT, $NCRA
24-7 Market News
What's Behind The Rise In Artelo Biosciences Stock?
Artelo Biosciences, Inc. (NASDAQ:ARTL) shares jumped on Monday after the company announced the publication of a peerreviewed article highlighting FABP5 as a therapeutic target for pain.read more...
Benzinga
Rogan’s Runners Market Ignites
The market is feeling the effect of Joe Rogan getting in President Trump’s ear and psychedelic therapeutics gaining regulatory tailwinds. Meanwhile, adjacent sectors are quietly building foundational breakthroughs. Wearables are evolving into neural interfaces, biomaterials are transitioning from lab curiosity to production reality, and oncology platforms continue their grind through clinical validation. $KBLB, $WLDS, $ARTL, $ENVB, $TOVX, $PBM, $CMND, $CMPS, $HELP,
24-7 Market News
Medical Stocks To Research - March 27th
UnitedHealth Group, Artelo Biosciences, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly...
MarketBeat
Artelo Biosciences Stock Skyrockets 205%
(RTTNews) - Shares of Artelo Biosciences, Inc. (ARTL) are skyrocketing about 205 percent on Friday morning trading despite no corporate-related announcements to influence the movement...
Nasdaq News: Markets
AI, Biotech, and Biologics Drive Big Narratives
A new wave of healthcare innovation, powered by artificial intelligence, next-generation biologics, and shifting regulatory pathways, is colliding with market dynamics to create both breakthrough potential and high-volatility trading setups. $ARTL, $TGNT, $ADMA, $RCKT, $LTRN, $GCTK
24-7 Market News
Artelo Biosciences Targets GLP-1 Boom with Muscle Preservation Strategy as Stock Eyes Squeeze Potential
Artelo Biosciences (NASDAQ:ARTL) is expanding the development pathway for its lead candidate ART27.13, positioning the compound as a potential companion therapy to GLP-1 weight-loss drugs, one of the fastest-growing segments in biopharma.
24-7 Market News
<
1
2
...
>